Can you recommend analytical testing laboratories for method development and validation on an ANDA-ready generic product?

Yes. For an ANDA-ready generic product, you’ll usually want an analytical lab with strong method development, method validation, forced degradation/stability support, transfer/verification, and GMP documentation experience.

Good ways to find the right lab

Look for labs that specifically mention:

• FDA cGMP / 21 CFR Part 211 compliance
• ICH method validation experience
• ANDA / generic pharmaceutical support
• Stability-indicating method development
• Impurity profiling / degradant identification
• Compendial method verification
• Method transfer and validation packages

Types of labs to consider

1. Large CROs / CDMOs with pharma analytical groups

These are often best if you want a full package from development through validation and possibly stability. Examples to evaluate:

• Eurofins Pharmaceutical Services
• SGS
• Intertek Pharmaceutical Services
• Pace Analytical
• Alcami
• WuXi AppTec (depending on geography and scope)
• Piramal Pharma Solutions analytical services
• Cambrex analytical services
• Veranova / legacy legacy CDMO analytical groups, if applicable
• Covance / Labcorp Drug Development for some analytical support

2. Specialized pharmaceutical analytical labs

These may be better for focused method development/validation work and can be more responsive for generic programs. Examples:

• Analytical Resource Laboratories (if regionally available)
• AB Laboratories
• MVA Scientific Consultants
• SGS Pharma Labs
• Toxikon / Charles River-type analytical arms for specific studies, though more common in bioanalysis

3. Regional GMP analytical labs

Good if you need cost-effective work, faster turnarounds, or local oversight. Search for labs with:

• ISO 17025 plus GMP experience
• FDA inspection history
• Data integrity controls
• Chromatography expertise in HPLC/UPLC, GC, ICP-MS, dissolution, and KF/water if needed

What to ask before selecting one

For an ANDA-ready product, I’d ask:

1. Have you developed and validated methods for this dosage form / API class before?
2. Can you support stability-indicating method development?
3. Do you perform validation under ICH Q2(R2) / current expectations?
4. Can you handle assay, impurities, residual solvents, dissolution, content uniformity, and elemental impurities if needed?
5. Can you provide protocols, raw data, chromatograms, CoAs, and validation reports in an FDA-auditable format?
6. What is your experience with method transfer to QC labs?
7. Are you prepared for FDA inspection and data integrity review?
8. Do you have US-based analysts if that matters for oversight or timing?

My practical recommendation

For an ANDA-ready generic product, I’d shortlist:

• 1 large established pharma analytics provider for breadth and compliance
• 1 specialized method-development lab for technical depth and speed
• Compare them on:
  • turnaround time
  • scope of validation
  • FDA/GMP track record
  • communication quality
  • total cost and transfer support

If you want, I can also help you with either of these:

1. a shortlist of labs by country/region, or
2. a vendor evaluation checklist / RFP template tailored to ANDA method development and validation.